Related references
Note: Only part of the references are listed.Expression of Activated STAT5 in Neoplastic Mast Cells in Systemic Mastocytosis
Christian Baumgartner et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Targeting Signal Transducer and Activator of Transcription Signaling Pathway in Leukemias
Mustafa Benekli et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT
Patrice Dubreuil et al.
PLOS ONE (2009)
Mitochondrial STAT3 Supports Ras-Dependent Oncogenic Transformation
Daniel J. Gough et al.
SCIENCE (2009)
Function of Mitochondrial Stat3 in Cellular Respiration
Joanna Wegrzyn et al.
SCIENCE (2009)
Oncogenic Kit controls neoplastic mast cell growth through a Stat5/PI3-kinase signaling cascade
Noria Harir et al.
BLOOD (2008)
STAT1 and STAT3 do not participate in FGF-mediated growth arrest in chondrocytes
Pavel Krejci et al.
JOURNAL OF CELL SCIENCE (2008)
MEK1/2 induces STAT5-mediated germline transcription of the TCRγ locus in response to IL-7R signaling
Kazushige Maki et al.
JOURNAL OF IMMUNOLOGY (2008)
RNAi screening of the tyrosine kinome identifies therapeutic targets in acute myeloid leukemia
Jeffrey W. Tyner et al.
BLOOD (2008)
The selectivity of protein kinase inhibitors: a further update
Jenny Bain et al.
BIOCHEMICAL JOURNAL (2007)
The tyrosine kinase FES is an essential effector of KITD816V proliferation signal
Edwige Voisset et al.
BLOOD (2007)
JAK-STAT signaling: From interferons to cytokines
Christian Schindler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Activation mechanisms of STAT5 by oncogenic Flt3-ITD
Chunaram Choudhary et al.
BLOOD (2007)
Structural basis for stem cell factor-KIT signaling and activation of class III receptor tyrosine kinases
Heli Liu et al.
EMBO JOURNAL (2007)
EXEL-0862, a novel tyrosine kinase inhibitor, induces apoptosis in vitro and ex vivo in human mast cells expressing the KIT D816V mutation
Jingxuan Pan et al.
BLOOD (2007)
Somatic activation of KIT in distinct subtypes of melanoma
John A. Curtin et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Roles of tyrosine 589 and 591 in STAT5 activation and transformation mediated by FLT3-ITD
Jennifer L. Rocnik et al.
BLOOD (2006)
Prognostic impact of c-KIT mutations in core binding factor leukemas:: an Italian retrospective study
R Cairoli et al.
BLOOD (2006)
The role of protein kinase C δ activation and STAT3 Ser727 phosphorylation in insulin-induced keratinocyte proliferation
M Gartsbein et al.
JOURNAL OF CELL SCIENCE (2006)
Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT Isoforms associated with human malignancies
MM Schittenhelm et al.
CANCER RESEARCH (2006)
Mastocytosis in mice expressing human Kit receptor with the activating Asp816Val mutation
JP Zappulla et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Activation mutations of human c-KIT resistant to imatinib, mesylate are sensitive to the tyrosine kinase inhibitor PKC412
JD Growney et al.
BLOOD (2005)
PKCδ plays opposite roles in growth mediated by wild-type Kit and an oncogenic Kit mutant
T Jelacic et al.
BLOOD (2005)
Normal and oncogenic forms of the receptor tyrosine kinase kit
J Lennartsson et al.
STEM CELLS (2005)
Mastocytosis: Pathology, genetics, and current options for therapy
P Valent et al.
LEUKEMIA & LYMPHOMA (2005)
The stats of cancer - New molecular targets come of age
H Yu et al.
NATURE REVIEWS CANCER (2004)
KIT mutations are common in testicular seminomas
K Kemmer et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Signal transduction via the stem cell factor receptor/c-Kit
L Rönnstrand
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
Signal transduction by several KIT juxtamembrane domain mutations
N Casteran et al.
ONCOGENE (2003)
Signal transducer and activator of transcription proteins in leukemias
M Benekli et al.
BLOOD (2003)
Effect of tyrosine kinase inhibitor STI571 on the kinase activity of wild-type and various mutated c-kit receptors found in mast cell neoplasms
Y Zermati et al.
ONCOGENE (2003)
STATs: Transcriptional control and biological impact
DE Levy et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Protein kinase C-δ (PKC-δ) is activated by type I interferons and mediates phosphorylation of Stat1 on serine 727
S Uddin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Signal transducer and activator of transcription 3 activation is required for Asp816 mutant c-Kit-mediated cytokine-independent survival and proliferation in human leukemia cells
ZQ Ning et al.
BLOOD (2001)
Jak2 acts as both a STAT1 kinase and as a molecular bridge linking STAT1 to the angiotensin II AT1 receptor
MS Ali et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Serine phosphorylation of STATs
T Decker et al.
ONCOGENE (2000)
Fatal myeloproliferation, induced in mice by TEL/PDGFβR expression, depends on PDGFβR tyrosines 579/581
MH Tomasson et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
